UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information...
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16...
OTTAWA, July 8 /CNW/ -- OTTAWA, July 8 /CNW/ - MDS Nordion, a leading provider of products and services to the global health science market...
MDS Nordion, Guerbet, and Cyceron Announce Partnership to Develop New Diagnostic Agents PR Newswire OTTAWA, June 24 Collaboration will Assess New...
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...
MDS Reports Second Quarter Fiscal 2010 Financial Results PR Newswire OTTAWA, June 14 OTTAWA, June 14 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS;...
MDS to Release Second Quarter 2010 Financial Results PR Newswire OTTAWA, June 7 OTTAWA, June 7 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:...
MDS Nordion Announces Changes to the Board PR Newswire OTTAWA, May 31 New Director Appointed and Two Directors Retire OTTAWA, May 31...
CUSIP No. 55269P302 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) Information to be included in...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities and Exchange Act of 1534 (Amendment...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.